Full-Time
Dispensing Pharmacist
Updated on 9/4/2026
Montu
1-10 employees
End-to-end medical cannabis platform
Compensation Overview
£35 - £40/hr
Winnersh, UK
In Person
 Medical, Clinical & Veterinary (1) |
|---|
Get referred to Montu
See people who can refer or advise you
- GPhC registration as a Pharmacist with relevant dispensing experience.
- Ability to work efficiently in a fast-paced setting.
- Strong attention to detail and commitment to patient safety.
- Excellent communication and teamwork skills.
- Work closely with the dispensing team to ensure efficient and accurate preparation of prescriptions while maintaining high regulatory and safety standards.
Montu is a health technology company focusing on Australia’s medical cannabis sector. It runs a vertically integrated system that covers the entire patient journey from telehealth consultations to medication delivery, including the Alternaleaf telehealth clinic, Leafio distribution, uMeds fulfillment, and its own portfolio of cannabis products. Alternaleaf connects patients with a large network of doctors and nurses for online consultations, after which a prescription can be issued and Montu handles the downstream supply chain to deliver the medicine. The company earns revenue from telehealth visits and product sales, and it differentiates itself through its integrated platform that combines production, prescription, and dispensing, though this model has drawn regulatory scrutiny. Montu’s goal is to expand access to medical cannabis in Australia and grow its platform and product offerings within the healthtech cannabis market.
Company Size
1-10
Company Stage
Early VC
Total Funding
$3.6M
Headquarters
Santiago, Chile
Founded
2019
Get referred to Montu
See people who can refer or advise you
Simplify's Take
What believers are saying
- Montu launched a Medical Affairs division in November 2025, signaling institutionalization.
- The January 2026 1800 MEDICARE rollout legitimizes telehealth, aiding Montu’s care pathway narrative.
- Montu’s 2025 pre-budget submission pushed TGA review, RWE funding, and prescriber education reform.
What critics are saying
- TGA Federal Court proceedings against Montu, Alternaleaf, and Strauch risk penalties and injunctions.
- Medicinal cannabis advertising restrictions threaten Alternaleaf acquisition if courts curtail online promotion in 2026.
- Regulatory tightening or adverse judgment could cripple Montu's clinic-brand model and founder credibility.
What makes Montu unique
- Alternaleaf serves 150,000+ patients yearly through Australia’s largest online cannabis clinic.
- Montu controls consultation, fulfillment, distribution, and brands, capturing margin across the patient journey.
- The 2025 Medical Affairs buildout adds rare clinical governance in a thinly regulated niche.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Paid Vacation
401(k) Company Match
401(k) Retirement Plan
Cycle to work scheme
Company News
Montu has named former Pharmacy Guild of Australia national president George Tambassis as a special adviser.
Montu is launching online clinic Alternaleaf in the UK, headed up by local managing director Asif Dewan.
Montu has joined forces with Chronic Pain Australia (CPA) to promote Pain Awareness Month in a bid to raise A$100,000 for the cause.
We are Montu. Our mission: Improve lives for millions of Australians through medical cannabis therapies.
Montu will use the funds to boost its marketing and attract more doctors on to the platform to service patients who need cannabidiol-related treatments.